NCT04223024 2025-03-05Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 2 Active not recruiting246 enrolled
NCT06771596 2025-01-13CC11Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Active not recruiting43 enrolled